DUBLIN--(BUSINESS WIRE)--The "Global Jet Injector Market Research and Forecast 2022-2028" report has been added to ResearchAndMarkets.com's offering.
The global Jet Injector market is growing at a considerable CAGR during the forecast period. The jet injector or needle-free device is a medical device that is used for vaccination and drug delivery by the high-pressure narrow jet of fluid. The major factors that are augmenting the growth of the market include the need for modern technologies in drug delivery technology, the growing prevalence of chronic diseases such as diabetes and cancer among others.
Furthermore, increasing demand for self-injection devices, reduction in risks such as cross-contamination, pain-free devices for patients, and various FDA and government approvals for the needle-free jet injectors are also estimated to be the major factors that are contributing significantly towards the growth of the market. In addition to this, the vaccination for the ongoing COVID-19 pandemic is expected to fuel the market. For Instance, Codagenix's intranasal COVID-19 vaccine does not require the needle to be administered.
However, certain factors are affecting the growth of the market. High development cost, and the need to ensure system sterility are the major constraints that will challenge the growth of the jet injector market across the globe. Conversely, technological advancement and rise in healthcare expenditures with the demand for biosimilar products are opportunities for the market to grow in the forecast period.
The Report Covers
- Market value data analysis of 2019 and forecast to 2026.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global female infertility diagnosis and treatment market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying 'who-stands-where' in the market.
Key Topics Covered:
1. Report Summary
2. Market Overview and Insights
3. Competitive Landscape
4. Market Determinants
5. Market Segmentation
6. Regional Analysis
7. Company Profiles
Companies Mentioned
- AKRADERMOJET
- Becton, Dickinson, and Co.
- European Pharma Group BV
- CODAGENIX, Inc.
- Crossject SA
- INJEX Pharma GmbH
- Ferring Pharmaceuticals Inc.
- Enesi Pharma Ltd.
- Medical International Technology, Inc.
- Merck KGaA
- Inovio Pharmaceuticals Inc.
- PharmaJet, Inc.
- Mylan NV
- Spirit Health Group Ltd.
- Zealand Pharma AS
- LEO Pharma Inc.
- Portal Instruments, Inc.
For more information about this report visit https://www.researchandmarkets.com/r/p6o9n
